LOAD MORE
You're viewed all 17 products
Fluphenazine
References
FAQ's
References
- Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives, Smith, Kline & French Laboratories, GB829246A, March 2, 1960
- Kelsey, M. I.; Keskiner, A.; Moscatelli, E. A., Gas-liquid chromatographic analysis of fluphenazine and fluphenazine sulfoxide in the urine of chronic schizophrenic patients, Journal of Chromatography, Volume: 75, Issue: 2, Pages: 294-7, 1973
Frequently Asked Questions
How are Fluphenazine impurities controlled?
Pharmaceutical manufacturers of Fluphenazine implement rigorous quality control measures to monitor and control impurity levels. These measures include using appropriate manufacturing processes, conducting thorough testing and analysis, and adhering to regulatory guidelines and specifications for impurity limits.
What are the potential sources of Fluphenazine impurities?
Impurities in Fluphenazine can arise from various sources, including raw materials, reagents during synthesis, degradation of the API over time, or by-products formed during the manufacturing process. Manufacturers need to identify and address these potential sources to maintain the purity of Fluphenazine.
How often are Fluphenazine impurities tested and monitored?
Impurities in Fluphenazine are regularly tested and monitored throughout the manufacturing process and the product's shelf life. Manufacturers conduct routine analysis and stability studies to assess impurity levels and ensure compliance with regulatory requirements. These tests help maintain the quality and integrity of Fluphenazine.
How should Fluphenazine impurities be stored in terms of temperature?
The recommendation is to store Fluphenazine impurities at a controlled room temperature, within 2-8 °C.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.